The ESETT Trial: 2nd Line Medications in Status Epilepticus
Background: Dealing with a patient in status epilepticus, refractory to treatment with benzodiazepines, can be a sphincter tightening ordeal. While most seizure activity responds to … Continue reading The ESETT Trial: 2nd Line Medications in Status Epilepticus
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
